Medtronic investigating cause of Sherpa Vector guiding catheter friction following safety alert.
This article was originally published in The Gray Sheet
Executive SummaryMEDTRONIC INVESTIGATING SHERPA VECTOR GUIDING CATHETER FRICTION that was the subject of a safety alert initiated by the firm in a Nov. 25, 1996 letter to physicians. The letter was sent after several physicians reported experiencing resistance when they attempted to pass interventional therapeutic devices through the lumen of the catheters.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.